SCIENTURE HOLDINGS, INC. Debt Instrument, Unamortized Discount (Premium), Net
SCIENTURE HOLDINGS, INC. (SCNX) had Debt Instrument, Unamortized Discount (Premium), Net of $62.47 thousand as of 2015-09-30, per its 10-Q filed 2015-11-02.
Discontinued › Notes › Debt › Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net › Debt Instrument, Unamortized Discount (Premium), Net
us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet · last filed 2015-11-02
- 2015-09-30: Debt Instrument, Unamortized Discount (Premium), Net $62.47K.
- 2014-12-31: Debt Instrument, Unamortized Discount (Premium), Net $0.00.
| Period end | Debt Instrument, Unamortized Discount (Premium), Net |
|---|---|
| 2015-09-30 | $62.47K 10-Q · filed 2015-11-02 |
| 2014-12-31 | $0.00 10-Q · filed 2015-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |